A press release dated February 7, 2020, from the US State Department, informs us that the Trump administration “facilitated” the shipment of 17.8 tons of masks, ventilators, gowns, and other supplies to China.
The CDC announced the first travel-related Covid-19 case in the United States on January 21, 2020. On January 30, 2020, the CDC announced the first person-to-person transmission in the United States. Epidemiologists, by the score, were warning us. Why did the Trump administration deem it necessary to get these supplies to China, a nation who made half of the surgical masks before Covid-19? China also manufacturers ventilators for export. Why were they sent ventilators from the United States.
We need to have a discussion around where these supplies came from, the process used to make the decision, and the planning that went into shipping these out versus planning for the epidemic in the United States.
Below is a copy of the entire press release:
The United States Announces Assistance To Combat the Novel Coronavirus
This week the State Department has facilitated the transportation of nearly 17.8 tons of donated medical supplies to the Chinese people, including masks, gowns, gauze, respirators, and other vital materials. These donations are a testament to the generosity of the American people.
Today, the United States government is announcing it is prepared to spend up to $100 million in existing funds to assist China and other impacted countries, both directly and through multilateral organizations, to contain and combat the novel coronavirus. This commitment – along with the hundreds of millions generously donated by the American private sector – demonstrates strong U.S. leadership in response to the outbreak.
This assistance only adds to what the United States has done to strengthen health security programs around the world. For the last 20 years, the United States through USAID has invested over one billion dollars to strengthen the capacity of more than 25 countries to prevent, detect, and respond to existing and emerging infectious disease threats. Since 2015, under our commitment to the Global Health Security Agenda (GHSA), this support has helped improve surveillance and laboratory systems, risk communication, outbreak response, and address the rising threat of anti-microbial resistance.
The United States is and will remain the world’s most generous donor. We encourage the rest of the world to match our commitment. Working together, we can have a profound impact to contain this growing threat.